Risk of future depression in people who are obese but metabolically healthy: the English longitudinal study of ageing

Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010; 67: 220–229.

Istvan J, Zavela K, Weidner G . Bodyweight and psychological distress in NHANES I. Int J Obes Relat Metab Disord 1992; 16: 999–1003.

Crisp AH, McGuiness B . Jolly fat: relation between obesity and psychoneurosis in general population. BMJ 1976; 1: 7–9.

Magnusson PK, Rasmussen F, Lawlor DA, Tynelius P, Gunnell D . Association of body mass index with suicide mortality: a prospective cohort study of more than one million men. Am J Epidemiol 2006; 163: 1–8.

Kivimäki M, Jokela M, Hamer M, Geddes J, Ebmeier K, Kumari M et al. Examining overweight and obesity as risk factors for common mental disorders using fat mass and obesity-associated (FTO) genotype-instrumented analysis: The Whitehall II Study, 1985–2004. Am J Epidemiol 2011; 173: 421–429.

Lawlor DA, Harbord R, Tybaerg-Hansen A . Using genetic loci to understand the relationship between adiposity and psychological distress: a Mendelian randomization study in the Copenhagen general population study of 53 221 adults. J Intern Med 2011; 269: 525–537.

Blüher M . The distinction of metabolically ‘healthy’ from ‘unhealthy’ obese individuals. Curr Opin Lipidol 2010; 21: 38–43.

Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 2008; 168: 1617–1624.

Kilpeläinen TO, Zillikens MC, Stanèákova A, Finucane FM, Ried JS, Langenberg C et al. Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet 2011; 43: 753–760.

Kopelman PG . Obesity as a medical problem. Nature 2000; 404: 635–643.

Whitlock G, Lewington S, Sherliker P . Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083–1096.

Katzmarzyk PT, Janssen I, Ross R, Church TS, Blair SN . The importance of waist circumference in the definition of metabolic syndrome: prospective analyses of mortality in men. Diabetes Care 2006; 29: 404–409.

Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the women's ischemia syndrome evaluation (WISE) study. Circulation 2004; 109: 706–713.

Song Y, Manson JE, Meigs JB, Ridker PM, Buring JE, Liu S . Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol 2007; 100: 1654–1658.

Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906–2912.

St-Pierre AC, Cantin B, Mauriège P, Bergeron J, Dagenais GR, Després JP et al. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. CMAJ 2005; 172: 1301–1305.

Calori G, Lattuada G, Piemonti L . Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona study. Diabetes Care 2011; 34: 210–215.

Arnlöv J, Ingelsson E, Sundström J, Lind L . Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010; 121: 230–236.

Flint AJ, Hu FB, Glynn RJ, Caspard H, Manson JE, Willett WC et al. Excess weight and the risk of incident coronary heart disease among men and women. Obesity 2010; 18: 377–383.

Akbaraly TN, Kivimäki M, Brunner EJ, Chandola T, Marmot MG, Singh-Manoux A et al. Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study. Diabetes Care 2009; 32: 499–504.

Koponen H, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Vanhala M . Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J Clin Psychiatry 2008; 69: 178–182.

Golden SH, Lazo M, Carnethon M, Bertoni AG, Schreiner PJ, Diez Roux AV et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA 2008; 299: 2751–2759.

Gale CR, Kivimaki M, Lawlor DA, Carroll D, Phillips AC, Batty GD . Fasting glucose, diagnosis of type 2 diabetes, and depression: the Vietnam experience study. Biol Psychiatry 2010; 67: 189–192.

Kivimäki M, Tabak AG, Batty GD, Singh-Manoux A, Jokela M, Akbaraly TN et al. Hyperglycemia, type 2 diabetes, and depressive symptoms: the British Whitehall II study. Diabetes Care 2009; 32: 1867–1869.

Howren MB, Lamkin DM, Suls J . Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71: 171–186.

ELSA user guide and documentation. UK Data Archive. http://www.data-archive.ac.uk/findingData/snDescription.asp?sn=5050 (accessed 21 August 2008).

Steffick DE . Documentation of Affective Functioning Measures in the Health and Retirement Study (HRS/AHEAD Documentation Report DR-005). Survey Research Center, University of Michigan, USA: Ann Arbor, MI, 2000 Available at: http://hrsonline.isr.umich.edu/docs/userg/dr-005.pdf.

Irwin M, Artin KH, Oxman MN . Screening for depression in the older adult: criterion validity of the 10-item center for epidemiological studies depression scale (CES-D). Arch Intern Med 1999; 159: 1701–1704.

Lyness JM, Noel TK, Cox C, King DA, Conwell Y, Caine ED . Screening for depression in elderly primary care patients. A comparison of the center for epidemiologic studies-depression scale and the geriatric depression scale. Arch Intern Med 1997; 157: 449–454.

Graig R, Deverill C, Pickering K . Quality control of blood, saliva and urine analytes. In: Spronston K, Mindell J (eds). Health Survey for England 2004, Methodology and Documentation. Vol. 2, The Information Centre: London, 2006, pp. 34–41.

Hamer M, Molloy GJ, Stamatakis E . Psychological distress as a risk factor for CVD events: pathophysiological and behavioural mechanisms. J Am Coll Cardiol 2008; 52: 2156–2162.

Zaninotto P, Pierce M, Breeze E, de Oliveira C, Kumari M . BMI and waist circumference as predictors of well-being in older adults: findings from the English longitudinal study of ageing. Obesity (Silver Spring) 2010; 18: 1981–1987.

Almeida OP, Calver J, Jamrozik K, Hankey GJ, Flicker L . Obesity and metabolic syndrome increase the risk of incident depression in older men: the health in men study. Am J Geriatr Psychiatry 2009; 17: 889–898.

Pulkki-Raback L, Elovainio M, Kivimaki M, Mattsson N, Raitakari OT, Puttonen S et al. Depressive symptoms and the metabolic syndrome in childhood and adulthood: a prospective cohort study. Health Psychol 2009; 28: 108–116.

Goldbacher EM, Bromberger J, Matthews KA . Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women. Psychosom Med 2009; 71: 266–272.

Hildrum B, Mykletun A, Midthjell K, Ismail K, Dahl AA . No association of depression and anxiety with the metabolic syndrome: the Norwegian hunt study. Acta Psychiatr Scand 2009; 120: 14–22.

Vogelzangs N, Beekman AT, Boelhouwer IG, Bandinelli S, Milaneschi Y, Ferrucci L et al. Metabolic depression: a chronic depressive subtype? Findings from the Inchianti study of older persons. J Clin Psychiatry 2011; 72: 598–604.

Carroll D, Phillips AC, Thomas GN, Gale CR, Deary I, Batty GD . Generalized anxiety disorder is associated with metabolic syndrome in the Vietnam experience study. Biol Psychiatry 2009; 66: 91–93.

Koenigsberg HW, Teicher MH, Mitropoulou V, Navalta C, New AS, Trestman R et al. 24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psych Res 2004; 38: 503–511.

Licht CM, Vreeburg SA, van Reedt Dortland AK . Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab 2010; 95: 2458–2466.

Mancia G, Bousquet P, Elghozi JL, Esler M, Grassi G, Julius S . The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007; 25: 909–920.

Rosmond R, Dallman MF, Björntorp P . Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 1998; 83: 1853–1859.

Yau PL, Javier DC, Ryan CM, Tsui WH, Ardekani BA, Ten S et al. Preliminary evidence for brain complications in obese adolescents with type 2 diabetes mellitus. Diabetologia 2010; 53: 2298–2306.

Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW . From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46–56.

Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK et al. A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67: 446–457.

Lindström J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemiö K et al. Finnish diabetes prevention study group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish diabetes prevention study. Lancet 2006; 368: 1673–1679.